Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127803631 | 12780363 | 1 | I | 20141128 | 20141201 | 20160926 | 20160926 | EXP | PHHY2014US181362 | NOVARTIS | 66.81 | YR | F | Y | 0.00000 | 20160926 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127803631 | 12780363 | 1 | PS | PROMACTA | ELTROMBOPAG OLAMINE | 1 | Unknown | UNK | 5ZP8973 | 22291 | TABLET | ||||||||
| 127803631 | 12780363 | 2 | SS | PROMACTA | ELTROMBOPAG OLAMINE | 1 | 22291 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127803631 | 12780363 | 1 | Thrombocytopenia |
| 127803631 | 12780363 | 2 | Aplastic anaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127803631 | 12780363 | HO |
| 127803631 | 12780363 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127803631 | 12780363 | Cough | |
| 127803631 | 12780363 | Dyspnoea | |
| 127803631 | 12780363 | Foot fracture | |
| 127803631 | 12780363 | Nasopharyngitis | |
| 127803631 | 12780363 | Oropharyngeal pain | |
| 127803631 | 12780363 | Pulmonary arterial hypertension |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127803631 | 12780363 | 1 | 20111111 | 0 |